Robert (Bob) Moccia is the new President and Chief Executive Officer and a member of the board of STRATA Skin Sciences, Inc. He replaces Dolev Rafaeli, PhD, who stepped down last month.
“I am confident that STRATA has the technology and team in place to be a leader in the treatment of dermatologic conditions,” says Mr. Moccia. “I look forward to immediately contributing to the Company’s unique and proven direct-to-consumer business model and working with the great team that has been assembled. I want to extend my gratitude to the board for their confidence in my ability to lead and grow this exciting company.”
Mr. Moccia has marketed and/or launched more than 30 dermatological products in the US and created over $1.2 billion in exit transactions. Most recently he served as President, CEO, and co-Founder of Encore Dermatology, Inc. Previously, he was CEO of Precision Dermatology, Inc., where the company’s revenues doubled to more than $100 million under his leadership and was subsequently acquired by Valeant Pharmaceuticals for approximately $500 million.
